Impact of neoadjuvant radiation therapy modalities on post-surgical lymphopenia in operable pancreatic cancer. Demographic characteristics of patients classified according to “two-two five-five” ...
The ETH spin-off, Page Therapeutics is already working on this solution. Aceto also wants to expand his research to other types of cancer that spread, such as prostate, colorectal or pancreatic cancer ...
Nivolumab plus ipilimumab (N+I) in patients (pts) with pancreatic cancer (PC) with BRCA1/2 mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study. Overall ...